We have recently announced the strategic acquisition of CIS Oncology, marking a significant expansion of our offerings in medicines management.  

Strategic Acquisition Enhances System C’s Medicines Management Capability

CIS Oncology is known for its innovative chemotherapy prescription and management system, ChemoCare. Widely adopted by NHS trusts, the chemotherapy care solution accelerates and streamlines prescribing and patient management through accessible technology. It provides enhanced convenience and reliability for NHS trusts. The company is set to launch ChemoPRO, an innovative app that will empower patients by providing instant access to their medical information. It enables seamless communication with healthcare professionals. CIS Oncology’s cancer informatics solutions streamline data management, enables precision medicine approaches and facilitates coordinated care. It empowers patients with personalised treatment plans and supports multidisciplinary cancer teams in making well-informed decisions.

The acquisition of the oncology technology company complements our existing portfolio of EPR, maternity and neonatal, prescribing and pharmacy solutions. Once integrated, customers will be able to manage the entire prescription journey with a single unified experience through which clinicians and oncologists can prescribe chemotherapy and non-chemotherapy drugs.

Nick Wilson, CEO of System C:

“We are delighted to welcome CIS Oncology to the System C family. This acquisition shows our commitment to delivering seamless care, prioritising patient and clinical safety and forging stronger connections with our customers as they embrace digital solutions across care. By integrating CIS Oncology’s expertise, we are now even better equipped to provide high-quality and cost-effective ePrescribing solutions. Not only do they meet our customers’ needs but reinforce our dedication to the NHS and our UK-centric approach. We’re looking forward to working together with CIS Oncology to leverage our collective expertise to significantly transform healthcare and shape the future of patient care.”

Tony Pegg, CEO at CIS Oncology:

“CIS Oncology Ltd has always been about working with our customers to improve patient outcomes in the safest and most efficient way possible. Joining forces with System C will strengthen that position across a broader offering to the NHS. We look forward to working together to continue helping the NHS and healthcare providers through further digitisation and, ultimately, ever improving patient outcomes.”

A Focus on Medicines Management & Patient Safety

The acquisition reflects our proactive approach to exploring how automating medicines management can lead to improved patient safety while easing the burden on the NHS.  Here at System C, we are already actively engaged with the Automating 4 better care (A4BC) forum. It’s chaired by Lord Carter, to define the priorities for medicines interoperability to feed into national funding prioritisation.

The Launch of CareFlow EPR

Earlier this year we announced the launch of its new look electronic patient record (EPR) solution, CareFlow EPR. It’s a fully integrated patient record solution that combines patient administration, clinical operations, maternity and neonatal capability, pharmacy and prescribing.

Next Steps

Explore our Resource Hub for a wide range of news articles, case studies, events and more.

For any inquiries or to speak directly with a team member, feel free to contact us today.